“Increasing Prevalence of Kidney Diseases”
The rising incidence of kidney diseases, such as chronic kidney disease (CKD) and end-stage renal disease (ESRD), is a leading cause for kidney transplants. As the number of kidney transplant surgeries grows, the demand for immunosuppressants increases. Diabetes, hypertension, and obesity are leading causes of CKD, and as these conditions become more prevalent globally, more patients are requiring kidney transplants. The kidney transplant immunosuppressant drugs market is poised for growth driven by an increasing patient population, advances in treatment options, and the development of newer, more effective drugs with fewer side effects. The focus is shifting toward more personalized medicine, improving long-term outcomes, and reducing the burden of immunosuppressant therapy on patients. With continued innovation, both in terms of drug development and treatment protocols, the market is expected to expand significantly in the coming years.
